Literature DB >> 166073

Proceedings: Experimental manipulation of the specific activity of poly(ADP-ribose) polymerase.

S Shall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 166073

Source DB:  PubMed          Journal:  J Biochem        ISSN： 0021-924X            Impact factor:   3.387


× No keyword cloud information.
  8 in total

1.  Induction of erythroid differentiation of murine erythroleukemia cells by nicotinamide and related compounds.

Authors:  M Terada; H Fujiki; P A Marks; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

Review 2.  PARP inhibitors: Synthetic lethality in the clinic.

Authors:  Christopher J Lord; Alan Ashworth
Journal:  Science       Date:  2017-03-16       Impact factor: 47.728

Review 3.  Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes.

Authors:  Carles Cantó; Anthony A Sauve; Peter Bai
Journal:  Mol Aspects Med       Date:  2013-01-25

4.  A versatile strategy for the design and synthesis of novel ADP conjugates and their evaluation as potential poly(ADP-ribose) polymerase 1 inhibitors.

Authors:  Yuliya V Sherstyuk; Alexandra L Zakharenko; Mikhail M Kutuzov; Polina V Chalova; Maria V Sukhanova; Olga I Lavrik; Vladimir N Silnikov; Tatyana V Abramova
Journal:  Mol Divers       Date:  2016-09-27       Impact factor: 2.943

Review 5.  Regulated necrosis: disease relevance and therapeutic opportunities.

Authors:  Marcus Conrad; José Pedro Friedmann Angeli; Peter Vandenabeele; Brent R Stockwell
Journal:  Nat Rev Drug Discov       Date:  2016-01-18       Impact factor: 84.694

Review 6.  PARPs in genome stability and signal transduction: implications for cancer therapy.

Authors:  Luca Palazzo; Ivan Ahel
Journal:  Biochem Soc Trans       Date:  2018-11-12       Impact factor: 5.407

7.  Combination of ligand and structure based virtual screening approaches for the discovery of potential PARP1 inhibitors.

Authors:  Mohammad M Al-Sanea; Garri Chilingaryan; Narek Abelyan; Michael Mamikonyan; Hayk Gasparyan; Sargis Hovhannisyan; Abdelrahman Hamdi; Ahmed R Ali; Samy Selim; Ahmed A B Mohamed
Journal:  PLoS One       Date:  2022-09-12       Impact factor: 3.752

Review 8.  PARP Inhibitors and Prostate Cancer: To Infinity and Beyond BRCA.

Authors:  Emily N Risdon; Cindy H Chau; Douglas K Price; Oliver Sartor; William D Figg
Journal:  Oncologist       Date:  2020-09-08       Impact factor: 5.837
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.